Package 42858-164-01

Brand: lisdexamfetamine dimesylate

Generic: lisdexamfetamine dimesylate
NDC Package

Package Facts

Identity

Package NDC 42858-164-01
Digits Only 4285816401
Product NDC 42858-164
Description

100 CAPSULE in 1 BOTTLE, PLASTIC (42858-164-01)

Marketing

Marketing Status
Marketed Since 2024-01-30
Brand lisdexamfetamine dimesylate
Generic lisdexamfetamine dimesylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "047c243d-9336-4ef2-b5a8-a7cae312b1be", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["d918b40d-a461-41bc-b6c0-83dc76c28e32"], "manufacturer_name": ["Rhodes Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (42858-164-01)", "package_ndc": "42858-164-01", "marketing_start_date": "20240130"}], "brand_name": "LISDEXAMFETAMINE DIMESYLATE", "product_id": "42858-164_047c243d-9336-4ef2-b5a8-a7cae312b1be", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "42858-164", "dea_schedule": "CII", "generic_name": "LISDEXAMFETAMINE DIMESYLATE", "labeler_name": "Rhodes Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISDEXAMFETAMINE DIMESYLATE", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "40 mg/1"}], "application_number": "ANDA215330", "marketing_category": "ANDA", "marketing_start_date": "20240130", "listing_expiration_date": "20261231"}